Dien et al. found a trend, although the results were not statistically significant for longer survival in patients with increased STAT3 activation, and hypothesized that pSTAT3 regulates Tissue Inhibitor of Metalloproteinase-1 (TIMP1), which makes breast cancer cells less invasive [20]. Here, STAT3 is linked to breast carcinoma.